Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DELTA LITHIUM LIMITED Capital/Financing Update 2019

Jul 18, 2019

64775_rns_2019-07-18_1731b696-a8cf-4d92-8749-2dfcf84d2c44.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ASX Announcement 19 July 2019

==> picture [150 x 52] intentionally omitted <==

Completion of Acquisition of Metals of Americas

TNT Mines Ltd (ASX: TIN, ‘TNT’ or ‘the Company’) , is pleased to advise that it has completed the acquisition of Metals of Americas LLC (‘MOA’).

Accordingly, TNT now holds the rights to the Pelley Ridge licence and the Bromley licence in Montana USA, collectively referred to as the Pelley Ridge Zinc Project, a highly prospective advanced zinc exploration asset.

Please see attached Appendix 3B in respect of performance shares issued as the consideration for the MOA acquisition.

--ends—

For further information, please contact:

Media Enquiries TNT Mines Ltd Luke Forrestal Brett Mitchell Media and Capital Partners Executive Chairman +61 411 479 144 +61 8 6319 1900 [email protected] [email protected]

==> picture [594 x 105] intentionally omitted <==

----- Start of picture text -----

TNT Mines | ACN 107 244 039 | tntmines.com.au
----- End of picture text -----

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

TNT Mines Limited

ABN

67 107 244 039

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of +securities issued or to be issued Performance Shares 2 Number of[+] securities issued or to be issued (if known) or maximum number which may 6,750,000 Performance Shares be issued 3 Principal terms of the[+] securities (e.g. if options, exercise price and expiry date; if Performance Shares Upon the Company announcing a JORC compliant partly paid +securities, the amount resource estimate for the Pelley Ridge Project of at outstanding and due dates for payment; if least “indicated” status of at least 2 million tonnes +convertible securities, the conversion price of at least 6% Zn equivalent each Performance and dates for conversion) Share will convert into a Share on a one for one basis. Each Performance Share will expire on the date that is 48 months from issue if the milestone has not been achieved.

  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

4
Do the+securities rank equally in all
respects from the+issue date with an
existing+class of quoted+securities?
If the additional+securities do not rank
equally, please state:

the date from which they do

the extent to which they participate for
the next dividend, (in the case of a trust,
distribution) or interest payment

the extent to which they do not rank
equally, other than in relation to the
next dividend, distribution or interest
payment
5
Issue price or consideration
6
Purpose of the issue
(If
issued
as
consideration
for
the
acquisition of assets, clearly identify those
assets)
6a
Is the entity an+eligible entity that has
obtained security holder approval under
rule 7.1A?
If Yes, complete sections 6b – 6h_in relation_
to the+securities the subject of this Appendix
3B, and comply with section 6i
6b
The date the security holder resolution
under rule 7.1A was passed
6c
Number of+securities issued without
security holder approval under rule 7.1
6d
Number of+securities issued with security
holder approval under rule 7.1A
6e
Number of+securities issued with security
holder approval under rule 7.3, or another
specific security holder approval (specify
date of meeting)
6f
Number of+securities issued under an
exception in rule 7.2
No – new class of securities, Performance Shares will
be unlisted. Upon conversion of the Performance
Shares new fully paid ordinary shares issued will rank
equally in all respects with fully paid ordinary shares.
Nil cash consideration – consideration for the
acquisition of 100% of issued capital in Metals of
Americas which holds the rights to the Pelley Ridge
Zinc Project, as detailed in the Notice of Meeting
dated 24 May 2019 and following shareholder
approval at the general meeting dated 2 July 2019
Acquisition of 100% issued capital in Metals of
Americas which holds the rights to the Pelley Ridge
Zinc Project as set out in the Company’s Notice of
Meeting
dated
24
May
2019
and
following
shareholder approval at the general meeting dated
2 July 2019.
Yes
29 November 2018
Nil
Nil
6,750,000 Performance Shares
as approved at the general meeting held
2 July 2019.
N/A
6g
If+securities issued under rule 7.1A, was
issue price at least 75% of 15 day VWAP as
calculated under rule 7.1A.3? Include the
+issue date and both values. Include the
source of the VWAP calculation.
N/A
6h
If+securities were issued under rule 7.1A for
non-cash consideration, state date on which
valuation of consideration was released to
ASX Market Announcements
N/A
6i
Calculate the entity’s remaining issue
capacity under rule 7.1 and rule 7.1A –
complete Annexure 1 and release to ASX
Market Announcements
4,573,287 under rule 7.1
3,048,858 under rule 7.1A
7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for a
pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
19 July 2019
Number
+Class
8
Number and+class of all+securities quoted
on ASX (including_the+securities in section
2 if applicable)
30,488,584
Fully Paid Ordinary Shares
Number
+Class
9
Number and+class of all
+securities not quoted on
ASX
(_including

the
+securities in section 2 if
applicable)
12,000,000
8,000,000
6,750,000
Unlisted Options exercisable at $0.25 expiring
24 October 2021
Unlisted Options exercisable at $0.25
expiring 30 June 2023
Performance Shares
10
Dividend policy (in the case
of a trust, distribution policy)
on the increased capital
(interests)
The Company does not have a dividend policy
6g
If+securities issued under rule 7.1A, was
issue price at least 75% of 15 day VWAP as
calculated under rule 7.1A.3? Include the
+issue date and both values. Include the
source of the VWAP calculation.
N/A
6h
If+securities were issued under rule 7.1A for
non-cash consideration, state date on which
valuation of consideration was released to
ASX Market Announcements
N/A
6i
Calculate the entity’s remaining issue
capacity under rule 7.1 and rule 7.1A –
complete Annexure 1 and release to ASX
Market Announcements
4,573,287 under rule 7.1
3,048,858 under rule 7.1A
7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for a
pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
19 July 2019
Number
+Class
8
Number and+class of all+securities quoted
on ASX (including_the+securities in section
2 if applicable)
30,488,584
Fully Paid Ordinary Shares
Number
+Class
9
Number and+class of all
+securities not quoted on
ASX
(_including

the
+securities in section 2 if
applicable)
12,000,000
8,000,000
6,750,000
Unlisted Options exercisable at $0.25 expiring
24 October 2021
Unlisted Options exercisable at $0.25
expiring 30 June 2023
Performance Shares
10
Dividend policy (in the case
of a trust, distribution policy)
on the increased capital
(interests)
The Company does not have a dividend policy
N/A N/A N/A
N/A
4,573,287 under rule 7.1
3,048,858 under rule 7.1A
19 July 2019
Number +Class
30,488,584 Fully Paid Ordinary Shares
Number +Class
12,000,000
8,000,000
6,750,000
Unlisted Options exercisable at $0.25 expiring
24 October 2021
Unlisted Options exercisable at $0.25
expiring 30 June 2023
Performance Shares
The Company does not have a dividend policy

Part 2 - Pro rata issue

11 Is security holder approval required? N/A 12 Is the issue renounceable or nonN/A renounceable? 13 Ratio in which the[+] securities will be N/A offered

  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

14
+Class of+securities to which the
offer relates
15
+Record
date
to
determine
entitlements
16
Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the
entity has security holders who will
not be sent new offer documents
Note: Security holders must be told
how their entitlements are to be dealt
with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount of any handling fee payable
to brokers who lodge acceptances or
renunciations on behalf of security
holders
25
If the issue is contingent on security
holders’ approval, the date of the
meeting
26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
27
If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell their
entitlements_in full_through a broker?
31
How do security holders sell_part_of
their entitlements through a broker
and accept for the balance?
32
How do security holders dispose of
their entitlements (except by sale
through a broker)?
33
+Issue date
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

  • (b) All other[+] securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

  • 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional[+] securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

ntities that have ticked box 34(b)
38
Number of+securities for which
+quotation is sought
39
+Class
of
+securities
for
which
quotation is sought
40
Do the+securities rank equally in all
respects from the+issue date with an
existing+class of quoted+securities?
If the additional+securities do not
rank equally, please state:
1.
the date from which they do
2.
the extent to which they
participate
for
the
next
dividend, (in the case of a
trust,
distribution)
or
interest payment
3.
the extent to which they do
not rank equally, other than
in relation to the next
dividend,
distribution
or
interest payment
41
Reason for request for quotation now
Example: In the case of restricted
securities, end of restriction period
(if issued upon conversion of another
+security, clearly identify that other
+security)
42
Number and+class of all+securities
quoted
on
ASX
(including
the
+securities in clause 38)
N/A
N/A
N/A
N/A
Number +Class
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ........................................................... Date 19 July 2019 (Company Secretary)

Print name: Lauren Nelson

== == == == ==

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

art 1 art 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
Insertnumber of fully paid+ordinary
securities on issue 12 months before the
+issue date or date of agreement to
issue
28,528,737 Ordinary Fully Paid Shares
Addthe following:

Number of fully paid+ordinary
securities issued in that 12 month
period under an exception in rule 7.2

Number of fully paid+ordinary
securities issued in that 12 month
period with shareholder approval

Number of partly paid+ordinary
securities that became fully paid in
that 12 month period
Note:

Include only ordinary securities here
– other classes of equity securities
cannot be added

Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed

It may be useful to set out issues of
securities on different dates as
separate line items
1 Nov 2017 – 1,709,847 Ordinary Fully Paid Shares
(escrowed until 1 November 2019)
18 Dec 2018 – 150,000 Ordinary Fully Paid Shares
6 March 2019 – 100,000 Ordinary Fully Paid Shares
Subtractthe number of fully paid
+ordinary securities cancelled during that
12 month period
Nil
“A” 30,488,584
  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A” Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 4,573,287
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been
used
Insertnumber of+equity securities issued or
agreed to be issued in that 12 month period_not_
counting_those issued:

Under an exception in rule 7.2

Under rule 7.1A

With security holder approval under rule 7.1
or rule 7.4
_Note:


This applies to equity securities, unless
specifically excluded – not just ordinary
securities

Include here (if applicable) the securities the
subject of the Appendix 3B to which this
form is annexed

It may be useful to set out issues of
securities on different dates as separate line
items
0
“C” 0
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule
7.1
“A” x 0.15
Note: number must be same as shown in Step 2
4,573,287
Subtract“C”
Note: number must be same as shown in Step 3
0
Total[“A” x 0.15] – “C” 4,573,287
[Note: this is the remaining placement capacity
under rule 7.1]
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule
7.1
“A” x 0.15 4,573,287
Note: number must be same as shown in Step 2
Subtract“C” 0
Note: number must be same as shown in Step 3
Total[“A” x 0.15] – “C” 4,573,287
[Note: this is the remaining placement capacity
under rule 7.1]

Part 2

art 2 art 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
“A”
Note: number must be same as shown in Step
1 of Part 1
30,488,584
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply“A” by 0.10 3,048,858
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already
been used
Insertnumber of+equity securities issued or
agreed to be issued in that 12 month period
under rule 7.1A
Notes:

This applies to equity securities – not just
ordinary securities

Include here – if applicable – the securities
the subject of the Appendix 3B to which
this form is annexed

Do not include equity securities issued
under rule 7.1 (they must be dealt with in
Part 1), or for which specific security holder
approval has been obtained

It may be useful to set out issues of
securities on different dates as separate
line items
0
“E” 0

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule
7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule
7.1A
“A” x 0.10
Note: number must be same as shown in Step
2
3,048,858
Subtract“E”
Note: number must be same as shown in Step
3
0
Total[“A” x 0.10] – “E” 3,048,858
[Note: this is the remaining placement capacity
under rule 7.1A]
  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013